Anna Gurevich‐Shapiro

434 total citations
11 papers, 226 citations indexed

About

Anna Gurevich‐Shapiro is a scholar working on Oncology, Immunology and Internal Medicine. According to data from OpenAlex, Anna Gurevich‐Shapiro has authored 11 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 3 papers in Internal Medicine. Recurrent topics in Anna Gurevich‐Shapiro's work include Venous Thromboembolism Diagnosis and Management (3 papers), Cancer Risks and Factors (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). Anna Gurevich‐Shapiro is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (3 papers), Cancer Risks and Factors (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). Anna Gurevich‐Shapiro collaborates with scholars based in Israel, Netherlands and Italy. Anna Gurevich‐Shapiro's co-authors include Ido Amit, Eyal David, Amir Giladi, Mor Zada, Cristian G. Beccaría, Baoguo Li, Jessica Le Bérichel, Iris Kamer, Miriam Mérad and Oren Barboy and has published in prestigious journals such as Cancer Discovery, Transfusion and Thrombosis Research.

In The Last Decade

Anna Gurevich‐Shapiro

10 papers receiving 222 citations

Peers

Anna Gurevich‐Shapiro
Kelley R. Jordan United States
Maria Aslani Germany
Julie Alejo United States
Kelley R. Jordan United States
Anna Gurevich‐Shapiro
Citations per year, relative to Anna Gurevich‐Shapiro Anna Gurevich‐Shapiro (= 1×) peers Kelley R. Jordan

Countries citing papers authored by Anna Gurevich‐Shapiro

Since Specialization
Citations

This map shows the geographic impact of Anna Gurevich‐Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gurevich‐Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gurevich‐Shapiro more than expected).

Fields of papers citing papers by Anna Gurevich‐Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gurevich‐Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gurevich‐Shapiro. The network helps show where Anna Gurevich‐Shapiro may publish in the future.

Co-authorship network of co-authors of Anna Gurevich‐Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gurevich‐Shapiro. A scholar is included among the top collaborators of Anna Gurevich‐Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gurevich‐Shapiro. Anna Gurevich‐Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gurevich‐Shapiro, Anna, Sharon Orbach‐Zinger, Avi Leader, et al.. (2024). Complement-mediated hemolytic uremic syndrome associated with postpartum hemorrhage: case series and systematic review of individual participant data. Research and Practice in Thrombosis and Haemostasis. 8(8). 102579–102579.
2.
Shapiro, Michael, et al.. (2023). Venous thromboembolism among physically active young adult females. Research and Practice in Thrombosis and Haemostasis. 7(8). 102236–102236. 1 indexed citations
3.
Yofe, Ido, Noam Cohen, Tomer Landsberger, et al.. (2023). Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary. Cancer Discovery. 13(12). 2610–2631. 62 indexed citations
4.
Cohen, Merav, Amir Giladi, Oren Barboy, et al.. (2022). The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response. Nature Cancer. 3(3). 303–317. 117 indexed citations
5.
Luttwak, Efrat, Anna Gurevich‐Shapiro, Foad Azem, et al.. (2021). Novel agents for the treatment of lymphomas during pregnancy: A comprehensive literature review. Blood Reviews. 49. 100831–100831. 4 indexed citations
6.
Aloush, Valerie, et al.. (2021). Relationship between religiosity, spirituality and physical and mental outcomes in fibromyalgia patients. Clinical and Experimental Rheumatology. 39(3). 48–53. 7 indexed citations
7.
Leader, Avi, Vincent ten Cate, Arina J. ten Cate‐Hoek, et al.. (2020). Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment. European Journal of Internal Medicine. 77. 86–96. 7 indexed citations
8.
Leader, Avi, Anna Gurevich‐Shapiro, & Galia Spectre. (2020). Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia. Thrombosis Research. 191. S68–S73. 11 indexed citations
9.
Gurevich‐Shapiro, Anna & Irit Avivi. (2019). Current treatment of lymphoma in pregnancy. Expert Review of Hematology. 12(6). 449–459. 10 indexed citations
10.
Gurevich‐Shapiro, Anna, Lilach Bonstein, Galia Spectre, et al.. (2017). Intravenous immunoglobulin–induced acute thrombocytopenia. Transfusion. 58(2). 493–497. 4 indexed citations
11.
Gurevich‐Shapiro, Anna, et al.. (2017). Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience. Acta Haematologica. 137(4). 183–190. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026